China Pharma (NYSE:CPHI) Coverage Initiated by Analysts at StockNews.com

Research analysts at StockNews.com began coverage on shares of China Pharma (NYSE:CPHI) in a report issued on Friday. The firm set a “hold” rating on the stock.

China Pharma Trading Up 3.7 %

Shares of CPHI opened at $0.20 on Friday. China Pharma has a fifty-two week low of $0.17 and a fifty-two week high of $1.16. The firm has a 50-day simple moving average of $0.23 and a 200-day simple moving average of $0.24. The company has a current ratio of 0.79, a quick ratio of 0.26 and a debt-to-equity ratio of 0.22.

About China Pharma

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.